Primecap Management’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-30,000
Closed -$262K 346
2025
Q1
$262K Sell
30,000
-97,600
-76% -$1.23M ﹤0.01% 332
2024
Q4
$1.83M Sell
127,600
-167,800
-57% -$2.65M ﹤0.01% 307
2024
Q3
$6.67M Buy
295,400
+108,600
+58% +$2.25M ﹤0.01% 276
2024
Q2
$3.63M Buy
186,800
+107,400
+135% +$2.81M ﹤0.01% 292
2024
Q1
$2.98M Buy
79,400
+48,000
+153% +$2.11M ﹤0.01% 301
2023
Q4
$1.76M Buy
31,400
+1,300
+4% +$56.6K ﹤0.01% 313
2023
Q3
$1.24M Buy
+30,100
New +$1.57M ﹤0.01% 314
2022
Q2
Sell
-3,300
Closed -$251K 343
2022
Q1
$251K Hold
3,300
﹤0.01% 337
2021
Q4
$492K Sell
3,300
-4,350
-57% -$666K ﹤0.01% 338
2021
Q3
$1.11M Hold
7,650
﹤0.01% 328
2021
Q2
$1.5M Hold
7,650
﹤0.01% 321
2021
Q1
$1.39M Hold
7,650
﹤0.01% 318
2020
Q4
$1.08M Hold
7,650
﹤0.01% 312
2020
Q3
$954K Hold
7,650
﹤0.01% 303
2020
Q2
$683K Hold
7,650
﹤0.01% 298
2020
Q1
$477K Buy
+7,650
New +$597K ﹤0.01% 285

Other funds holding TXG